Cardiff Oncology, Inc. Financial Ratios — CRDF Stock

Profitability (USD)

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Return on Common Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Assets (%)	-288.65	-182.08	-60.85	-51.11	-54.75	-67.95	-88.58	-124.44	-120.43	-26.12	-19.9	-29.13	-41.9	-50.81	-57.65
Return on Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Invested Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Gross Margin (%)	100	100	100	94.49	-101.14	-354.12	-258.41	-57.92	100	100	100	100	100	100	100
EBITDA Margin (%)	-1,151.17	-1,067.33	-4,073.36	-5,250.36	-7,958.44	-10,046.82	-4,387.38	-4,104.74	-6,615.76	-5,087.43	-7,911.98	-10,276.17	-9,224.18	-6,985.07	-8,103.88
Operating Margin (%)	-1,155.16	-1,076.62	-4,123.71	-5,334.17	-8,079.5	-10,327.49	-4,634.22	-4,331.92	-6,817.79	-5,214.75	-8,037.6	-10,337.31	-9,305.74	-7,123.13	-8,256.32
Incremental Operating Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Pretax Margin (%)	-868.94	-2,567.91	-4,555.88	-5,112.99	-8,781.98	-10,287.75	-4,928.09	-4,351.07	-6,709.74	-5,275.14	-7,880.5	-10,026.94	-8,492.01	-6,651.68	-7,732.04
Profit Margin (%)	-868.94	-2,567.91	-4,555.88	-5,112.99	-8,781.98	-10,287.75	-4,928.09	-4,351.07	-6,709.74	-5,275.14	-7,880.5	-10,026.94	-8,492.01	-6,651.68	-7,732.04
Net Income to Common Margin (%)	-883.77	-2,576.4	-4,567.39	-5,121.21	-8,789.73	-10,294.11	-4,932.88	-5,089.53	-6,829.31	-6,174.32	-7,887.19	-10,033.16	-8,496.93	-6,655.2	-7,736.26
Effective Tax Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Dvd Payout Ratio (%)	1.68	0.33	0.25	0.16	0.09	0.06	0.1	14.51	1.75	14.56	0.08	0.06	0.06	0.05	0.05
Sustainable Growth Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Credit (USD)

API Chat

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Total Debt	- -	- -	1	15	16	17	1	- -	2	1	3	3	2	2	1
ST Debt	- -	- -	- -	2	5	2	1	- -	1	1	1	1	1	1	1
LT Debt	- -	- -	- -	13	11	14	- -	- -	1	- -	3	2	1	1	- -
Total Debt/EBITDA	- -	- -	-0.05	-1.02	-0.66	-0.43	-0.06	- -	-0.11	-0.05	-0.11	-0.07	-0.05	-0.03	-0.02
Net Debt/EBITDA	0.24	2.25	2.4	0.84	2.05	-0.07	0.31	0.74	0.63	7.03	0.42	0.41	0.48	1.08	0.36
Total Debt/EBIT	- -	- -	-0.05	-1	-0.65	-0.42	-0.06	- -	-0.1	-0.05	-0.11	-0.07	-0.05	-0.03	-0.02
Net Debt/EBIT	0.24	2.23	2.37	0.83	2.02	-0.07	0.29	0.7	0.61	6.86	0.41	0.41	0.48	1.06	0.36
EBITDA to Interest Expense	-52.38	- -	-621	-17.44	-16.32	-22.87	-21.45	-611.17	- -	-9,310	- -	- -	- -	- -	- -
EBITDA-CapEx/Interest Expense	-52.38	- -	-621	-17.44	-16.32	-22.87	-21.45	-611.17	- -	-9,310	- -	- -	- -	- -	- -
EBIT to Interest Expense	-52.56	- -	-628.67	-17.72	-16.57	-23.5	-22.65	-645	- -	-9,543	- -	- -	- -	- -	- -
Interest Expense	- -	- -	- -	1	2	2	1	- -	- -	- -	- -	- -	- -	- -	- -
Common Equity/Total Assets	-4,195.05	-473.22	-246.88	-281.66	-152.4	-337	-1,408.56	-1,356.03	-1,596.22	-171.82	-173.73	-256.56	-415.91	-395.28	-694.89
Long-Term Debt/Equity (%)	- -	- -	1.58	156.33	23.09	71.71	- -	- -	11.78	0.01	1.83	1.92	2.09	0.98	0.22
Long-Term Debt/Capital (%)	- -	- -	-0.49	-19.65	-12.17	-10.77	- -	- -	-0.42	- -	-1	-0.69	-0.43	-0.21	-0.02
Long-Term Debt/Total Assets (%)	- -	- -	1.19	45.17	15.74	32.26	- -	- -	6.58	0.01	1.72	1.76	1.79	0.84	0.16
Total Debt/Equity (%)	- -	- -	2.56	179.07	33.82	83.65	20.47	- -	23.61	0.68	2.22	2.55	3.08	1.84	1.83
Total Debt/Capital (%)	- -	- -	-0.78	-22.5	-17.82	-12.57	-0.78	- -	-0.83	-0.38	-1.22	-0.92	-0.64	-0.4	-0.19
Total Debt/Total Assets (%)	- -	- -	1.92	51.74	23.06	37.63	10.84	- -	13.19	0.65	2.09	2.34	2.63	1.57	1.34
Net Debt to Equity	16.55	-498.83	-124.15	-147.82	-104.76	13.26	-105.97	-113.58	-139.44	-102.2	-8.51	-15.37	-31.05	-62.05	-38.49
Net Debt/Capital (%)	1.58	16.39	27.41	13.17	31.91	-1.8	3.83	5.62	4.69	36.22	4.45	5.24	6.03	11.86	3.91
EBITDA	-3	-5	-11	-15	-25	-38	-22	-16	-16	-19	-28	-40	-45	-48	-48
EBITDA-CapEx	-3	-5	-11	-15	-25	-38	-22	-16	-16	-19	-28	-40	-45	-48	-48
Operating Income (Loss)	-3	-5	-11	-15	-25	-39	-23	-16	-17	-19	-29	-40	-45	-49	-49

Liquidity (USD)

API Chat

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Cash Ratio	0.49	14.81	12.86	6.08	8.23	4.86	2.08	3.92	2.13	21.41	21.47	13.48	7.17	6.83	3.56
Current Ratio	0.59	15.13	12.98	6.18	8.34	5	2.4	4.37	2.37	21.79	22.28	14.25	7.41	7.08	3.67
Quick Ratio	0.56	15.04	12.9	6.09	8.24	4.87	2.1	3.98	2.17	21.46	21.55	13.58	7.19	6.89	3.57
CFO/Avg Current Liab	-0.8	-4.57	-5.34	-3.92	-3.49	-3.88	-3.97	-3.84	-3.44	-2.99	-3.63	-4.71	-3.39	-3.16	-2.54
Common Equity/Total Assets	-4,195.05	-473.22	-246.88	-281.66	-152.4	-337	-1,408.56	-1,356.03	-1,596.22	-171.82	-173.73	-256.56	-415.91	-395.28	-694.89
Long-Term Debt/Equity (%)	- -	- -	1.58	156.33	23.09	71.71	- -	- -	11.78	0.01	1.83	1.92	2.09	0.98	0.22
Long-Term Debt/Capital (%)	- -	- -	-0.49	-19.65	-12.17	-10.77	- -	- -	-0.42	- -	-1	-0.69	-0.43	-0.21	-0.02
Long-Term Debt/Total Assets (%)	- -	- -	1.19	45.17	15.74	32.26	- -	- -	6.58	0.01	1.72	1.76	1.79	0.84	0.16
Total Debt/Equity (%)	- -	- -	2.56	179.07	33.82	83.65	20.47	- -	23.61	0.68	2.22	2.55	3.08	1.84	1.83
Total Debt/Capital (%)	- -	- -	-0.78	-22.5	-17.82	-12.57	-0.78	- -	-0.83	-0.38	-1.22	-0.92	-0.64	-0.4	-0.19
Total Debt/Total Assets (%)	- -	- -	1.92	51.74	23.06	37.63	10.84	- -	13.19	0.65	2.09	2.34	2.63	1.57	1.34
CFO/Total Liabilities	-36.62	-51.97	-108.18	-61.94	-97.25	-128.36	-402.87	-322.85	-229.73	-248.36	-252.44	-343.42	-259.6	-264.68	-229.89
CFO/CapEx	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Altman's Z-Score	-64.97	-1.18	4.96	-2.3	1.45	-5.24	-24.32	-20.85	-25.16	32.56	13.47	0.07	-3.33	2.54	-4.65

Working Capital (USD)

API Chat

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Accounts Receivable Turnover	2.96	3.37	2.1	4.13	4.03	3.83	5.69	3.09	1.32	1.4	0.84	0.59	0.92	1.29	1.24
Days Sales Outstanding	123.33	108.4	174.14	88.38	90.68	95.4	64.11	118.11	276.95	261.02	434.64	617.47	396.04	283.5	293.91
Inventory Turnover	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Days Inventory Outstanding	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Accounts Payable Turnover	- -	- -	- -	0.03	0.7	1.59	1.85	0.8	- -	- -	- -	- -	- -	- -	- -
Accounts Payable Turnover Days	- -	- -	- -	12,225.85	518.81	229	197.04	455.16	- -	- -	- -	- -	- -	- -	- -
Cash Conversion Cycle	- -	- -	- -	-12,137.46	-428.13	-133.6	-132.93	-337.05	- -	- -	- -	- -	- -	- -	- -
Inventory to Cash Days	- -	- -	- -	88.38	90.68	95.4	64.11	118.11	- -	- -	- -	- -	- -	- -	- -
Inventories	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Raw Materials	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Work In Process	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Finished Goods	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Enterprise Value (USD)

API Chat

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Market Capitalization	32	91	97	81	141	63	11	7	7	376	235	61	66	207	188
- Cash & Cash Equivalents	1	11	26	27	67	14	8	11	10	131	12	16	22	51	17
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Total Debt	- -	- -	1	15	16	17	1	- -	2	1	3	3	2	2	1
Enterprise Value	31	80	72	69	90	42	4	-4	-1	245	97	-42	-7	117	130
Total Capital	-44	-55	-67	-66	-92	-132	-172	-192	-207	-231	-257	-295	-337	-383	-429
Total Debt/Capital (%)	- -	- -	-0.78	-22.5	-17.82	-12.57	-0.78	- -	-0.83	-0.38	-1.22	-0.92	-0.64	-0.4	-0.19
Total Debt / EV	- -	- -	0.01	0.22	0.18	0.39	0.35	- -	-1.63	- -	0.03	-0.07	-0.33	0.01	0.01
EV/Sales	121.65	177.03	278.26	246.08	289.21	110.24	7.63	- -	- -	670.57	269.83	- -	- -	170.69	219.82
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Free Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Diluted Market Cap	32	91	97	82	143	64	11	7	7	376	235	61	66	207	188
Diluted Enterprise Value	31	80	72	70	92	66	4	-4	-1	245	226	47	47	157	171
EV per Share	232.41	439.34	305.92	262.59	248.6	100.24	8.01	- -	- -	11.76	2.48	- -	- -	2.45	1.95
TTM Sales	- -	- -	- -	- -	- -	- -	1	- -	- -	- -	- -	- -	- -	1	1
TTM EBITDA	-3	-5	-11	-15	-25	-38	-22	-16	-16	-19	-28	-40	-45	-48	-48
TTM Operating Income	-3	-5	-11	-15	-25	-39	-23	-16	-17	-19	-29	-40	-45	-49	-49
TTM Cash Flow to Firm	-2	-5	-7	-12	-21	-29	-22	-13	-13	-16	-23	-34	-31	-38	-38
TTM Free Cash Flow to Firm	-2	-5	-7	-12	-21	-29	-22	-13	-13	-16	-23	-34	-31	-38	-38

Multiples (USD)

API Chat

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Price/Free Cash Flow	-16.6	-18.35	-13.32	-6.44	-6.46	-2.05	-0.46	-0.56	-0.56	-23.02	-10.18	-1.8	-2.14	-5.49	-4.95
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Enterprise Value	31	80	72	69	90	42	4	-4	-1	245	97	-42	-7	117	130
Low Price	34.56	133.92	346.32	213.84	303.12	128.16	17.28	3	0.88	0.7	4.88	1.13	0.94	1.44	1.9
EV/Sales	121.65	177.03	278.26	246.08	289.21	110.24	7.63	- -	- -	670.57	269.83	- -	- -	170.69	219.82
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings Average	-11.42	-4.56	-9.73	-6.28	-6.79	-3.43	-1.48	-1.52	-0.9	-6.44	-11.26	-2.54	-1.68	-3.12	-4.38
Price/Earnings High	-24.31	-8.73	-14.73	-9.35	-12.94	-5.33	-3.34	-4.18	-3.45	-23.56	-27.27	-8.24	-3.01	-6.73	-7.27
Price/Earnings Low	-2.05	-2.09	-6.9	-3.91	-4.01	-1.37	-0.33	-0.36	-0.31	-0.65	-6.73	-1.27	-1.01	-1.51	-2.77
Price/Book Value	-0.74	-1.64	-1.45	-1	-1.3	-0.43	-0.06	-0.04	-0.04	-1.62	-0.9	-0.2	-0.19	-0.54	-0.44
Price/Book Value Average	-0.6	-0.96	-1.72	-1.11	-1.71	-0.91	-0.21	-0.15	-0.07	-0.63	-1.23	-0.33	-0.2	-0.37	-0.47
Price/Book Value High	-1.27	-1.83	-2.6	-1.65	-3.27	-1.41	-0.48	-0.42	-0.28	-2.3	-2.97	-1.07	-0.37	-0.8	-0.78
Price/Book Value Low	-0.11	-0.44	-1.22	-0.69	-1.01	-0.36	-0.05	-0.04	-0.03	-0.06	-0.73	-0.17	-0.12	-0.18	-0.3
Price/Tangible Book Value	-7.57	41.75	4.78	9.74	2.91	3.21	1.65	0.73	1.01	2.93	1.67	0.57	0.95	2.49	4.14
Price/Tangible Book Value Average	-6.15	24.41	5.65	10.79	3.83	6.8	5.66	2.91	2.06	1.14	2.27	0.93	1	1.71	4.43
Price/Tangible Book Value High	-13.08	46.69	8.55	16.08	7.31	10.58	12.79	7.98	7.88	4.15	5.5	3	1.79	3.69	7.35
Price/Tangible Book Value Low	-1.1	11.21	4	6.72	2.27	2.72	1.28	0.69	0.72	0.11	1.36	0.46	0.6	0.83	2.8
Price/Sales	124.36	201.05	375.92	290.13	452.32	166.29	21.27	19.58	30.28	1,026.07	653.4	158.13	135.5	302.78	316.73
Price/Sales Average	100.93	117.53	444.52	321.49	596.76	352.8	72.9	77.57	61.64	397.67	888.27	255.33	142.41	207.84	338.99
Price/Sales High	214.81	224.84	672.59	479.05	1,137.49	548.75	164.68	212.8	235.66	1,454.41	2,150.46	826.82	255.43	447.9	562.46
Price/Sales Low	18.09	53.96	315.01	200.39	352.64	140.95	16.47	18.47	21.49	39.92	530.55	127.64	86.06	100.46	214.16
Price/Cash Flow	-16.6	-18.35	-13.32	-6.39	-6.4	-2.04	-0.46	-0.56	-0.56	-23.02	-10.18	-1.8	-2.14	-5.49	-4.95
Price/Cash Flow Average	-13.47	-10.73	-15.75	-7.08	-8.44	-4.33	-1.58	-2.22	-1.14	-8.92	-13.84	-2.91	-2.25	-3.77	-5.3
Price/Cash Flow High	-28.68	-20.52	-23.83	-10.55	-16.09	-6.74	-3.58	-6.1	-4.35	-32.63	-33.51	-9.44	-4.04	-8.12	-8.8
Price/Cash Flow Low	-2.41	-4.93	-11.16	-4.41	-4.99	-1.73	-0.36	-0.53	-0.4	-0.9	-8.27	-1.46	-1.36	-1.82	-3.35
Price/Free Cash Flow Average	-13.47	-10.73	-15.75	-7.14	-8.52	-4.35	-1.58	-2.22	-1.14	-8.92	-13.84	-2.91	-2.25	-3.77	-5.3
Price/Free Cash Flow High	-28.68	-20.52	-23.83	-10.64	-16.24	-6.76	-3.58	-6.1	-4.35	-32.63	-33.51	-9.44	-4.04	-8.12	-8.8
Price/Free Cash Flow Low	-2.41	-4.93	-11.16	-4.45	-5.03	-1.74	-0.36	-0.53	-0.4	-0.9	-8.27	-1.46	-1.36	-1.82	-3.35
EV/Sales Average	98.22	93.51	346.87	277.44	433.65	359.68	59.26	47.29	27.02	42.18	863.69	220.01	102.44	134.71	310.94
EV/Sales High	212.09	200.82	574.94	435	974.39	555.63	151.04	182.53	201.04	1,098.91	2,125.88	791.5	215.46	374.77	534.4
EV/Sales Low	15.37	29.94	217.36	156.34	189.54	147.83	2.83	- -	- -	- -	505.97	92.32	46.09	27.33	186.1
EV/EBITDA Average	-8.53	-8.76	-8.52	-5.28	-5.45	-3.58	-1.35	-1.15	-0.41	-0.83	-10.92	-2.14	-1.11	-1.93	-3.84
EV/EBITDA High	-18.42	-18.81	-14.11	-8.29	-12.24	-5.53	-3.44	-4.45	-3.04	-21.6	-26.87	-7.7	-2.34	-5.37	-6.59
EV/EBITDA Low	-1.34	-2.81	-5.34	-2.98	-2.38	-1.47	-0.06	0.29	0.2	6.2	-6.39	-0.9	-0.5	-0.39	-2.3
EV/EBIT Average	-8.5	-8.69	-8.41	-5.2	-5.37	-3.48	-1.28	-1.09	-0.4	-0.81	-10.75	-2.13	-1.1	-1.89	-3.77
EV/EBIT High	-18.36	-18.65	-13.94	-8.15	-12.06	-5.38	-3.26	-4.21	-2.95	-21.07	-26.45	-7.66	-2.32	-5.26	-6.47
EV/EBIT Low	-1.33	-2.78	-5.27	-2.93	-2.35	-1.43	-0.06	0.27	0.19	6.05	-6.3	-0.89	-0.5	-0.38	-2.25
Last Price	237.6	498.96	413.28	309.6	388.8	151.2	22.32	3.18	1.24	17.99	6.01	1.4	1.48	4.34	2.81
High Price	410.4	558	739.44	511.2	977.76	498.96	172.8	34.56	9.65	25.5	19.78	7.32	2.79	6.42	4.99
Enterprise Value Average	25	42	90	78	136	137	30	18	7	15	310	85	50	92	184
Enterprise Value High	55	90	149	122	305	212	76	69	49	402	763	306	105	256	317
Enterprise Value Low	4	13	56	44	59	56	1	-4	-3	-115	182	36	22	19	110

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Shares Outstanding	- -	- -	- -	- -	- -	- -	1	4	9	37	42	45	45	67	68
Diluted Weighted Avg Shares	- -	- -	- -	- -	- -	- -	- -	2	6	21	39	44	45	48	67
Basic Weighted Avg Shares	- -	- -	- -	- -	- -	- -	- -	2	6	21	39	44	45	48	67
Revenue per Share	1.91	2.48	1.1	1.07	0.86	0.91	1.05	0.16	0.04	0.02	0.01	0.01	0.01	0.01	0.01
EBITDA per Share	-21.99	-26.49	-44.78	-56.03	-68.41	-91.35	-46.04	-6.67	-2.71	-0.89	-0.73	-0.91	-1.01	-1	-0.72
Operating Income per Share	-22.07	-26.72	-45.34	-56.92	-69.45	-93.9	-48.63	-7.04	-2.79	-0.91	-0.74	-0.92	-1.02	-1.02	-0.73
Basic EPS, GAAP	-16.88	-63.94	-50.21	-54.65	-75.55	-93.6	-51.76	-8.27	-2.8	-1.08	-0.73	-0.89	-0.93	-0.95	-0.69
Basic EPS from Cont Ops	-16.6	-63.73	-50.09	-54.56	-75.49	-93.54	-51.71	-7.07	-2.75	-0.92	-0.72	-0.89	-0.93	-0.95	-0.69
Diluted EPS, GAAP	-16.88	-63.94	-50.21	-54.17	-74.84	-93.27	-51.76	-8.27	-2.8	-1.08	-0.73	-0.89	-0.93	-0.95	-0.69
Diluted EPS from Cont Ops	-16.6	-63.73	-50.09	-54.08	-74.77	-93.22	-51.71	-7.07	-2.75	-0.92	-0.72	-0.89	-0.93	-0.95	-0.69
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	-14.31	-27.19	-31.03	-48.48	-60.78	-74.06	-48.33	-5.67	-2.22	-0.78	-0.59	-0.78	-0.69	-0.79	-0.57
Free Cash Flow per Basic Share	-14.31	-27.19	-31.03	-48.48	-60.78	-74.06	-48.33	-5.67	-2.22	-0.78	-0.59	-0.78	-0.69	-0.79	-0.57
Cash & Equivalents per Share	5.19	59.62	109.57	103.95	185.46	90.42	17.08	4.92	1.71	6.27	3.61	2.41	1.67	1.93	0.87
Book Value per Share	-323.23	-304.16	-284.31	-309.99	-299.2	-353.41	-359.26	-82.5	-34.97	-11.09	-6.66	-6.84	-7.6	-8.06	-6.43
Tangible Book Value per Share	-31.37	11.95	86.48	31.8	133.83	47.17	13.51	4.33	1.22	6.14	3.6	2.44	1.56	1.74	0.68

Cardiff Oncology, Inc.

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)